English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Interventional treatment has become the golden standard for many congenital heart diseases and pathologies that were just recently considered unsuitable for an interventional approach are now being successfully treated by those who are most experienced. Still, being on the cutting-edge is a source of uncertainty and risk. New technologies, like rapid prototyping also know as three-dimensional (3D) printing may help to reduce this uncertainty. It has been demonstrated that 3D printed models are helpful in planning surgical and interventional treatment of various congenital heart diseases of unusual anatomy [1, 2]. Less is known of application 3D printing for planning and rehearsing management of rare complications of previous treatments.

Feasibility of in-house rapid prototyping of cardiovascular three-dimensional models for planning and training non-standard interventional procedures